#Cholesterol
articles
Health
Lipfendra vs Statins: What the FDA's First Oral PCSK9 Inhibitor Means for High Cholesterol
The FDA approved Lipfendra (enlicitide), the first oral PCSK9 inhibitor, on July 16, 2026 — a new daily-pill add-on for ...
Health
EU Regulator Backs NewAmsterdam's Cholesterol Drug Obicetrapib, Opening Path to Market
The EMA's CHMP has recommended approval of obicetrapib (Ubeslo) and its fixed-dose combo with ezetimibe (Evlarco) for pr...